1 0
Cart
    Inquiry
    Popular Searches: Recombinant Antibody MHC Tetramer T cell Receptor Scaffold Protein

    EGFR & CD28

    Loading...

    Anti-EGFR & CD28 Products

    + Filter
    Loading...
    • Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-037CL)
      • Target: EGFR
      • Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
      • Drug: MMAE (Monomethyl auristatin E)
      Go to compare Compare
    • Anti-EGFR-MC-VC-PABA-MMAE ADC (ADC-038CL)
      • Target: EGFR
      • Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
      • Drug: MMAE (Monomethyl auristatin E)
      Go to compare Compare
    • Anti-EGFR-mc-MMAF ADC (ADC-039CL)
      • Target: EGFR
      • Linker: Mc (maleimidocaproyl)
      • Drug: MMAF (Monomethyl auristatin F)
      Go to compare Compare
    • Anti-EGFR-vc-PAB-MODO ADC (ADC-263CL)
      • Target: epidermal growth factor receptor (EGFR)
      • Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
      • Drug: MODO (monomethyldolastatin)
      Go to compare Compare
    • Anti-EGFR (clone J2898A)-SMCC-DM1 ADC (ADC-047LZY)
      • Target: EGFR
      • Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
      • Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
      Go to compare Compare
    • Anti-EGFR (MAb806)-SMCC-DM1 ADC (ADC-110LCT)
      • Target: EGFR variant III
      • Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
      • Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
      Go to compare Compare
    • Anti-EGFRvIII-SMCC-DM1 ADC (ADC-048LZY)
      • Target: EGFRvIII
      • Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
      • Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
      Go to compare Compare
    • Anti-EGFR-MCC-Dox ADC (ADC-057LZY)
      • Target: EGFR
      • Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
      • Drug: doxorubicin
      Go to compare Compare
    • Anti-EGFR-EDC/NHS-Dox ADC (ADC-058LZY)
      • Target: EGFR
      • Linker: EDC/NHS(1-ethyl-3-(3-diaminopropyl)carbodiimide/N-hydroxysuccinimide)
      • Drug: doxorubicin
      Go to compare Compare
    • Anti-EGFR-SMCC-methotrexate ADC (ADC-059LZY)
      • Target: EGFR
      • Linker: SMCC (N-succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate)
      • Drug: MTX
      Go to compare Compare
    • Anti-EGFR (J2898A)-SMCC-DM1 ADC (IMGN289) (ADC-L016)
      • Target: EGFR
      • Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
      • Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto- 1-oxopropyl)maytansine)
      Go to compare Compare
    View More Products

    Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

    More Infomation

    Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

    For Research Use Only. Not For Clinical Use.


    Background

    CD28 (Cluster of Differentiation 28) is one of the proteins expressed on T cells that provide co-stimulatory signals required for T cell activation and survival. T cell stimulation through CD28 in addition to the T-cell receptor (TCR) can provide a potent signal for the production of various interleukins (IL-6 in particular).
    EGFR & CD28
    Receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. Is involved in the control of cell growth and differentiation. Phosphorylates MUC1 in breast cancer cells and increases the interaction of MUC1 with SRC and CTNNB1/beta-catenin. Isoform 2 may act as an antagonist of EGF action.
    EGFR & CD28
    Related Diseases
    Bladder Cancer Bladder Cancer
    Non-small Cell Lung Cancer Non-small Cell Lung Cancer
    Pancreatic Cancer Pancreatic Cancer
    Rheumatoid Arthritis Rheumatoid Arthritis
    Systemic Lupus Erythematosus Systemic Lupus Erythematosus
    Hepatocellular Carcinoma Hepatocellular Carcinoma
    Allograft Rejection Allograft Rejection
    Autoimmune Thyroid Disease Autoimmune Thyroid Disease
    Graft-versus-Host Disease Graft-versus-Host Disease
    Maturity Onset Diabetes of the Young Maturity Onset Diabetes of the Young
    Cushing Syndrome Cushing Syndrome
    Related Signaling Pathways
    JAK-STAT Signaling Pathway JAK-STAT Signaling Pathway
    Go to compare

    Go to compare